Please use this identifier to cite or link to this item:
https://doi.org/10.1039/c9na00248k
DC Field | Value | |
---|---|---|
dc.title | A MoS2-MWCNT based fluorometric nanosensor for exosome detection and quantification | |
dc.contributor.author | Tayebi, M. | |
dc.contributor.author | Tavakkoli Yaraki, M. | |
dc.contributor.author | Yang, H.Y. | |
dc.contributor.author | Ai, Y. | |
dc.date.accessioned | 2021-12-17T06:08:27Z | |
dc.date.available | 2021-12-17T06:08:27Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Tayebi, M., Tavakkoli Yaraki, M., Yang, H.Y., Ai, Y. (2019). A MoS2-MWCNT based fluorometric nanosensor for exosome detection and quantification. Nanoscale Advances 1 (8) : 2866-2872. ScholarBank@NUS Repository. https://doi.org/10.1039/c9na00248k | |
dc.identifier.issn | 25160230 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/210979 | |
dc.description.abstract | Circulating exosomes in body fluids are involved in many diseases and have important roles in pathophysiological processes. Specifically, they have emerged as a promising new class of biomarkers in cancer diagnosis and prognosis because of their high concentration and availability in a variety of biological fluids. The ability to quantitatively detect and characterize these nano-sized vesicles is crucial to make use of exosomes as a reliable biomarker for clinical applications. However, current methods are mostly technically challenging and time-consuming which prevents them from being adopted in clinical practice. In this work, we have developed a rapid sensitive platform for exosome detection and quantification by employing MoS2-multiwall carbon nanotubes as a fluorescence quenching material. This exosome biosensor shows a sensitive and selective biomarker detection. Using this MoS2-MWCNT based fluorometric nanosensor to analyze exosomes derived from MCF-7 breast cancer cells, we found that CD63 expression could be measured based on the retrieved fluorescence of the fluorophore with a good linear response range of 0-15% v/v. In addition, this nanosensing technique is able to quantify exosomes with different surface biomarker expressions and has revealed that exosomes secreted from MCF-7 breast cancer cells have a higher CD24 expression compared to CD63 and CD81. © 2019 The Royal Society of Chemistry. | |
dc.publisher | Royal Society of Chemistry | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc/4.0/ | |
dc.source | Scopus OA2019 | |
dc.type | Article | |
dc.contributor.department | CHEMICAL & BIOMOLECULAR ENGINEERING | |
dc.description.doi | 10.1039/c9na00248k | |
dc.description.sourcetitle | Nanoscale Advances | |
dc.description.volume | 1 | |
dc.description.issue | 8 | |
dc.description.page | 2866-2872 | |
Appears in Collections: | Students Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1039_c9na00248k.pdf | 1.48 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License